The early findings from the SERENA-6 trial indicate that the investigational oral SERD camizestrant provides a “highly ...

In this interview with Dr. Maria de Miguel, we explore the transformative potential of Antibody-Drug Conjugates (ADCs) in ...

Francis Medical, developing water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, announced ...

A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a ...

AI is evolving fast and life sciences is feeling the impact. In 2025, its role will expand even further, driving efficiencies ...

Bayer continues to form new partnerships to expand its targets for cancer treatment, recently collaborating with MOMA and ...

IMUNON announced that its new DNA-based immunotherapy for advanced ovarian cancer has shown encouraging results in the ...

ONCOLife proudly presents an exclusive interview with Dr. Joana Reis, Global Medical Affairs Lead, Breast Imaging, Radiology at Bayer. In this session, we explore how AI-driven advancements are ...

New data for darolutamide confirm safety and improved efficacy across subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) by 40% and 70% respectively, compared to placebo ...